CRISPR assisted RNA trans-splicing for controlled and transient activation of T cells
Conferences
Lanvanya, HV; Fiflis, D; Sewell, B; Asokan, A
Published in: MOLECULAR THERAPY
April 28, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2025
Volume
33
Issue
4
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Lanvanya, H. V., Fiflis, D., Sewell, B., & Asokan, A. (2025). CRISPR assisted RNA trans-splicing for controlled and transient activation of T cells. In MOLECULAR THERAPY (Vol. 33).
Lanvanya, Harshitha Venugopal, David Fiflis, Beatrice Sewell, and Aravind Asokan. “CRISPR assisted RNA trans-splicing for controlled and transient activation of T cells.” In MOLECULAR THERAPY, Vol. 33, 2025.
Lanvanya HV, Fiflis D, Sewell B, Asokan A. CRISPR assisted RNA trans-splicing for controlled and transient activation of T cells. In: MOLECULAR THERAPY. 2025.
Lanvanya, Harshitha Venugopal, et al. “CRISPR assisted RNA trans-splicing for controlled and transient activation of T cells.” MOLECULAR THERAPY, vol. 33, no. 4, 2025.
Lanvanya HV, Fiflis D, Sewell B, Asokan A. CRISPR assisted RNA trans-splicing for controlled and transient activation of T cells. MOLECULAR THERAPY. 2025.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2025
Volume
33
Issue
4
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics